In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.
World
·
Ozempic Is About to Go Generic in India, China and Canada
CN
CitrixNews Staff
Originally reported by New York Times
Related Articles
World
US intelligence agencies not expecting China to invade Taiwan in 2027
twitterwhatsappcopylinkgoogleAdd Al Jazeera on GoogleinfoDefensive structures on Shiyu, or Lion Islet, which is part of ...
CitrixNews Staff
·
1 hour ago
World
Iran executes three convicted of killing police in recent pre-war unrest
twitterwhatsappcopylinkgoogleAdd Al Jazeera on GoogleinfoThe aftermath of an Israeli strike on Evin Prison after the cea...
CitrixNews Staff
·
1 hour ago
World
Luka Doncic scores 40 points as Lakers defeat Rockets in NBA
twitterwhatsappcopylinkgoogleAdd Al Jazeera on GoogleinfoLos Angeles Laker guard Luka Doncic, left, celebrates with team...
CitrixNews Staff
·
1 hour ago
World
Power prices expected to fall by up to 10% from July, bringing ‘welcome relief’ to Australia’s east coast
Increased output from wind generation and batteries, and falling electricity contract prices, are expected to deliver lo...
CitrixNews Staff
·
1 hour ago